Sign in
4

Changes in Ownership

Moleculin Biotech, Inc. Filed Acc 0001437749-23-016003

Options or other derivatives

  • Director acquired 15,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Cermak Elizabeth Director 2023-05-25 Grant or award · Stock option (right to buy) +15,000 70,000 D
Loading xslF345X04/rdgdoc.xml…